Prothena | PRTA - Trade Debtors



Prothena reported $0 in Trade Debtors for its fiscal quarter ending in December of 2024.


Trade Debtors Change Date
Acadia Pharmaceuticals USD 119.69M 5.97M Jun/2025
Agios Pharmaceuticals USD 4.99M 1.64M Jun/2025
ALKERMES USD 356.33M 34.58M Jun/2025
Alnylam Pharmaceuticals USD 567.11M 149.08M Jun/2025
Amgen USD 8.7B 569M Jun/2025
Biogen USD 2.08B 87.5M Jun/2025
BioMarin Pharmaceutical USD 855.85M 116.68M Jun/2025
Exelixis USD 292.35M 10.72M Jul/2025
Incyte USD 842.89M 19.76M Jun/2025
Ionis Pharmaceuticals USD 52.58M 12.87M Jun/2025
MacroGenics USD 12.53M 8.22M Jun/2025
Neurocrine Biosciences USD 595.7M 79.7M Jun/2025
Prothena USD 0 0 Dec/2024
Regeneron Pharmaceuticals USD 5.61B 49M Jun/2025
Ultragenyx Pharmaceutical USD 124.46M 25.62M Jun/2025
Vertex Pharmaceuticals USD 1.89B 88.4M Jun/2025